logo
Is There Anything Nicer than NICE? A Question the Conservative Shadow Health Team Is Right to Ask
Can NICE Be Nicer? In a World of Budget Constraints There Are No Easy Solutions
Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer
The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data
Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population
Cost-Effectiveness of Posaconazole versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infections among Neutropenic Patients in the United States
A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective
Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis
Age-Based Programs for Vaccination against HPV
Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population
Health-Care Costs of Pediatric Clients Developing Adverse Events during Treatment with Antipsychotics
Obesity and Incremental Hospital Charges among Patients with and without Diabetes in the United States
The Transferability of Economic Evaluations: Testing the Model of Welte
Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods
Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries
What Is the Best Strategy for Diagnosis and Treatment of Helicobacter pylori in the Prevention of Recurrent Peptic Ulcer Bleeding? A Cost-Effectiveness Analysis
Hypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of Life and Health Burden
The Linkage between Pediatric Quality of Life and Health Conditions: Establishing Clinically Meaningful Cutoff Scores for the PedsQL
Rasch Measurement Properties of the KIDSCREEN Quality of Life Instrument in Children with Cerebral Palsy and Differential Item Functioning between Children with and without Cerebral Palsy
Valuing Condition-Specific Health States Using Simulation Contact Lenses
Deriving a Patient-Based Utility Index from a Cancer-Specific Quality of Life Questionnaire
Challenges of Patient-Reported Outcome Assessment in Hemophilia Care—a State of the Art Review
Feasibility, Reliability, and Validity of Three Health-State Valuation Methods Using Multiple-Outcome Vignettes on Moderate-Risk Pregnancy at Term
Item Reduction and Psychometric Validation of the Oily Skin Self Assessment Scale (OSSAS) and the Oily Skin Impact Scale (OSIS)
The Impact of Two Pharmaceutical Risk-Sharing Agreements on Pricing, Promotion, and Net Health Benefits